Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2000
12/28/2000WO2000078319A1 Dihydropyrazine derivatives as npy antagonists
12/28/2000WO2000078313A1 Arylthiazolidinedione and aryloxazolidinedione derivatives
12/28/2000WO2000078311A1 Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
12/28/2000WO2000078303A1 Non-malignant disease treatment with ras antagonists
12/28/2000WO2000078293A1 New formulation
12/28/2000WO2000078266A2 Interferon tau mutants and methods for making them
12/28/2000WO2000078247A1 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
12/28/2000WO2000055162A3 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
12/28/2000WO2000054780A3 Corticosteroid formulation
12/28/2000WO2000043495A3 33 human secreted proteins
12/28/2000WO2000043373A3 Kinase inhibitors
12/28/2000WO2000035465A3 Oral administration of lactobacillus for the treatment and prevention of urogenital infection
12/28/2000WO1999052493A3 Compounds that inhibit the binding of integrins to their receptors
12/28/2000CA2382425A1 Interferon tau mutants and methods for making them
12/28/2000CA2377698A1 Dihydropyrazine derivatives as npy antagonists
12/28/2000CA2377530A1 Compositions and methods for the treatment or prevention of autoimmune disorders
12/28/2000CA2377524A1 Novel anti-allergic agents
12/28/2000CA2377246A1 Arylthiazolidinedione and aryloxazolidinedione derivatives
12/28/2000CA2376284A1 A method for the prophylaxis and/or treatment of medical disorders
12/28/2000CA2375781A1 Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abci
12/28/2000CA2375493A1 Human transport proteins
12/28/2000CA2375407A1 Rna metabolism proteins
12/28/2000CA2375282A1 Potassium channel openers
12/28/2000CA2375268A1 Indoloazepines as vasopressin receptor antagonists
12/28/2000CA2375265A1 Polymorphs of crystalline azo-bicyclo 2,2,2,oct-3-yl amine dihydrochloride and their pharmaceutical compositions
12/28/2000CA2373375A1 Combination of lactic acid bacteria and its use for the prevention and/or treatment of infections and inflammatory conditions
12/28/2000CA2371924A1 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
12/28/2000CA2340319A1 Method for producing plants with increased flavonoid and phenolic compound content
12/27/2000EP1063293A2 Transforming growth factor alpha H1
12/27/2000EP1062951A1 Preventive and therapeutic agent for fatty liver
12/27/2000EP1062236A1 31 human secreted proteins
12/27/2000EP1062222A1 Serine peptidase modulators
12/27/2000EP1062216A1 Inhibitors of phospholipase a2
12/27/2000EP1062215A1 Antagonists of gonadotropin releasing hormone
12/27/2000EP1062210A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors
12/27/2000EP1061926A2 Heterocyclic compounds, their production and use as tachykinin receptor antagonists
12/27/2000EP1061922A1 USE OF $i(N)-SUBSTITUTED-1,5-DIDEOXY-1,5-IMINO-D-GLUCITOL COMPOUNDS FOR TREATING HEPATITIS VIRUS INFECTIONS
12/27/2000EP1061911A2 Novel methods for treating disorders in which docosahexaenoic acid (dha) levels are affected
12/27/2000EP1061909A1 Keto acid salts and amine derivatives, and their use for preparing medicines
12/27/2000EP1061812A1 Food products having enhanced cocoa polyphenol content and processes for producing same
12/27/2000EP0821671B1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors
12/27/2000EP0821666B1 Derivatives of succinamide and their use as metalloproteinase inhibitors
12/27/2000CN1278263A 2,3-diaryl-pyrazolo [1,5-B] pyridazines derivatives, their prepn. and use as cyclooxygenase 2 (cox-2) inhibitors
12/27/2000CN1278255A Cyclopentene derivatives useful as antagonists of the motilin receptor
12/27/2000CN1278247A Alpha-hydroxy, amino and -fluoro derivatives of beta-sulphenyl hydroxamic acids matrix metalloproteinases inhibitors
12/27/2000CN1278182A Citrus peel extract as inhibitor of acyl CoA-cholesterol-0-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall
12/27/2000CN1278176A Use of quinazoline derivatives as tyrosine kinase inhibitors for treating colonic polyps
12/27/2000CN1278174A Nicotine compositions and method for formulation thereof
12/27/2000CN1278171A Naringin and naringenin as inhibitor of acyl coa-cholesterol-o-acyltransferase, ihibitor of macrophage-lipid complex accumulation on the arterial wall and preventive agent
12/27/2000CN1278170A Hesperidin and hesperetin as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive agent
12/27/2000CN1277962A Novel substituted dipolymer compounds, prepn. method therefor, pharmaceutical compositions contg. same
12/27/2000CN1277857A Traditional Chinese medicine for tonifying spleen and expelling dampness
12/27/2000CN1277853A Anti-fatigue farmaceutical and its prepn. process
12/27/2000CN1277851A Pharmaceutical for treating gastroduodenal ulcer and gastritis, and its prepn. process
12/27/2000CN1059834C Pure traditional Chinese medicinal liquor with antisenile action
12/27/2000CN1059832C Medical cigarette for treating tooth ache and its preparing method
12/27/2000CN1059830C Medicine for Meniere's disease
12/27/2000CN1059821C Medicine for treating gastroenteritic diseases
12/27/2000CN1059811C Morning medicine of Chinese medicine preparations for curing hepatitis B
12/27/2000CN1059802C Medicine for tooth transplantation and producing process thereof
12/26/2000US6166219 Treatment of diabetes and related disorders
12/26/2000US6166213 Omeprazole process and compositions thereof
12/26/2000US6166206 Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments
12/26/2000US6166193 Nucleotide sequence which encodes g-protein coupled receptor; for the treatment and prevention of bacterial, fungal, protozoan and viral infections; for use in gene therapy
12/26/2000US6166064 Antiinflammatory agents; antiarthritic agents
12/26/2000US6166060 Antihistamines; sleep disorders; central nervous system disorders
12/26/2000US6166055 Antiinflammatory agents
12/26/2000US6166049 A treatment and/or prophylaxis of hyperglycaemia, pre-diabetic insulin resistance syndrome by administering an agonist of peroxisome proliferator-activated receptor to stimulate fatty oxidation
12/26/2000US6166048 Pharmaceutical compositions for inhibition of cytokine production and secretion
12/26/2000US6166040 Treating a disorder of the central nervous system
12/26/2000US6166039 Peripherally active anti-hyperalgesic opiates
12/26/2000US6166031 An inhibitor of 5-lipoxygenase enzyme, a blocking agents of leukotriene receptors; useful in the prevention or treatment of asthma, arthritis, psoriasis, ulcers, myocardial infarction
12/26/2000US6166005 Heterocyclic metalloprotease inhibitors
12/26/2000US6166002 Substituted phenylalkenoylguanidines, process for their preparation, and their use in medicaments and in diagnostics
12/26/2000US6165984 Administering an effective amount of naringin or naringenin to the human to prevent acylcoa-cholesterol-o-acyltransferase activity to treat hepatic diseases; inhibiting accumulation of macrophage-lipid complex on the arterial endothelium
12/26/2000US6165513 Film-coated tablet for improved upper gastrointestinal tract safety
12/26/2000US6165503 Preparing gelled beads of a polyanionic polysaccharide which are cross-linked with a polyvalent cation, forming capsules having polycationic-polyanion membrane of polycationic polysaccharide on gelled beads, culturing the product capsule
12/26/2000US6165447 Synergistic combination of about 0.003 to about 2.0% by weight triclosan and about 0.003 to about 2.0% by weight of a mixture of hexahydrocolupulone and hexahydrolupulone.
12/23/2000CA2312432A1 Use of melatoninergic ligands to obtain pharmaceutical compositions for the prevention or treatment of pathologies in the gastrointestinal system
12/21/2000WO2000077256A1 48 human secreted proteins
12/21/2000WO2000077255A1 49 human secreted proteins
12/21/2000WO2000077233A2 Complement-resistant non-mammalian dna viruses and uses thereof
12/21/2000WO2000077199A1 Cloning and expression of a novel 5-ht4 receptor
12/21/2000WO2000077197A1 47 human secreted proteins
12/21/2000WO2000077179A2 Human poly(adp-ribose) polymerase 2 materials and methods
12/21/2000WO2000077166A2 Gene expression modulated in gastrointestinal inflammation
12/21/2000WO2000077040A2 Human intracellular signaling molecules
12/21/2000WO2000077023A1 48 human secreted proteins
12/21/2000WO2000077021A1 48 human secreted proteins
12/21/2000WO2000077018A2 Purine derivatives
12/21/2000WO2000077010A2 Substituted heterocycle fused gamma-carbolines
12/21/2000WO2000077009A1 DITHIEPINO[6,5-b]PYRIDINES, AND RELATED COMPOSITIONS AND METHODS
12/21/2000WO2000077003A1 Optically active pyrrolopyridazine compounds
12/21/2000WO2000077002A1 Substituted heterocycle fused gamma-carbolines
12/21/2000WO2000077001A1 Substituted heterocycle fused gamma-carbolines
12/21/2000WO2000076971A2 Serine protease inhibitors
12/21/2000WO2000076958A2 Mono- and disubstituted 3-propyl gamma-aminobutyric acids
12/21/2000WO2000076531A1 47 human secreted proteins
12/21/2000WO2000076530A1 49 human secreted proteins
12/21/2000WO2000076523A1 Methods for modulating fxr receptor activity
1 ... 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 ... 1258